...
首页> 外文期刊>Transplant international : >What is the significance of end‐stage renal disease risk estimation in living kidney donors?
【24h】

What is the significance of end‐stage renal disease risk estimation in living kidney donors?

机译:生活肾脏捐赠者终末期肾病风险估算有何意义?

获取原文
获取原文并翻译 | 示例

摘要

Summary Two end‐stage renal disease ( ESRD ) risk calculators were recently developed by Grams et al ., and Ibrahim et al . to calculate ESRD risk before donation among living kidney donors. However, those calculators have never been studied among potential donors for whom donation was refused due to medical contraindications and compared to a group of donors. We compared 15‐year and lifetime ESRD risk of donors and nondonors due to medical cause as estimated by those two calculators. Nondonors due to medical cause ( n = 27) had a significantly higher 15‐year ESRD risk compared to donors ( n = 288) with both calculators (0.25 vs. 0.14, P 0.001 for that developed by Grams et al . and 2.21 vs. 1.43, P = 0.002 for that developed by Ibrahim et al .). On the contrary, lifetime ESRD risk was not significantly different between the two groups. At both times (15 years and lifetime), we observed a significant overlap of ESRD risk between the two groups. ESRD risk calculators could be complementary to standard screening strategy but cannot be used alone to accept or decline donation.
机译:发明内容最近由Grams等人开发了两个终末期肾病(ESRD)风险计算器。和Ibrahim等人。在捐赠生活肾脏捐赠者之前计算ESRD风险。然而,这些计算器从未在潜在的捐赠者之间研究过,因为捐赠因医学禁忌症而被拒绝,并与一群捐赠者相比。由于这两个计算器估计,我们将15年和捐助者和非安理会的终身估计风险相得到。由于医疗原因(n = 27),与供体(n = 288)相比,与两个计算器(0.25 Vs. 0.14,P <0.001)的供体(n = 288)具有明显更高的15年的ESRD风险(由Grams等人开发的2.21与Ibrahim等人开发的那样,vs. 1.43,p = 0.002。)。相反,两组之间的终身ESRD风险不会显着差异。在两次(15年和寿命),我们观察到两组之间的ESRD风险显着重叠。 ESRD风险计算器可以与标准筛查策略互补,但不能单独使用以接受或拒绝捐赠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号